The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Bateman, David James
    Director born in February 1974
    Individual (3 offsprings)
    Officer
    2022-12-05 ~ now
    OF - Director → CIF 0
  • 2
    Murphy, Rebecca Anne, Dr
    Senior Research Clinician born in October 1976
    Individual (1 offspring)
    Officer
    2022-12-05 ~ now
    OF - Director → CIF 0
  • 3
    Shao, Lingyun
    Ceo born in August 1977
    Individual (1 offspring)
    Officer
    2023-09-01 ~ now
    OF - Director → CIF 0
  • 4
    Schoppig, Joel
    Investor born in August 1985
    Individual (2 offsprings)
    Officer
    2024-03-27 ~ now
    OF - Director → CIF 0
  • 5
    OXFORD SCIENCES INNOVATION PLC - 2021-09-30
    OXFORD SCIENCES PLC - 2015-03-17
    46, Woodstock Road, Oxford, England
    Active Corporate (11 parents, 66 offsprings)
    Person with significant control
    2022-12-05 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 3
  • 1
    Chamas, Liliane
    Investor born in October 1986
    Individual (4 offsprings)
    Officer
    2022-12-05 ~ 2024-03-27
    OF - Director → CIF 0
  • 2
    Mr David James Bateman
    Born in February 1974
    Individual (3 offsprings)
    Person with significant control
    2022-10-25 ~ 2022-12-01
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 3
    Oancea, Cristian
    Company Director born in April 1989
    Individual (1 offspring)
    Officer
    2022-10-25 ~ 2024-02-14
    OF - Director → CIF 0
    Mr Cristian Oancea
    Born in April 1989
    Individual (1 offspring)
    Person with significant control
    2022-10-25 ~ 2022-12-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

CREDO THERAPIES LTD

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Average Number of Employees
102022-10-25 ~ 2023-12-31
Intangible Assets
47,500 GBP2023-12-31
Property, Plant & Equipment
3,937 GBP2023-12-31
Fixed Assets
51,437 GBP2023-12-31
Debtors
Current
225,951 GBP2023-12-31
Cash at bank and in hand
2,289,261 GBP2023-12-31
Current Assets
2,515,212 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-38,245 GBP2023-12-31
Net Current Assets/Liabilities
2,476,967 GBP2023-12-31
Total Assets Less Current Liabilities
2,528,404 GBP2023-12-31
Net Assets/Liabilities
2,528,404 GBP2023-12-31
Equity
Called up share capital
208 GBP2023-12-31
Share premium
1,699,898 GBP2023-12-31
Other miscellaneous reserve
2,000,000 GBP2023-12-31
Retained earnings (accumulated losses)
-1,171,702 GBP2023-12-31
Equity
2,528,404 GBP2023-12-31
Property, Plant & Equipment - Depreciation rate used
Office equipment
332022-10-25 ~ 2023-12-31
Wages/Salaries
406,315 GBP2022-10-25 ~ 2023-12-31
Social Security Costs
42,911 GBP2022-10-25 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
457,413 GBP2022-10-25 ~ 2023-12-31
Intangible Assets - Gross Cost
Computer software
50,000 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
4,830 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
893 GBP2022-10-25 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
893 GBP2023-12-31
Property, Plant & Equipment
Office equipment
3,937 GBP2023-12-31
Other Debtors
Current
195,919 GBP2023-12-31
Prepayments/Accrued Income
Current
30,032 GBP2023-12-31
Cash and Cash Equivalents
2,289,261 GBP2023-12-31
Trade Creditors/Trade Payables
Current
17,383 GBP2023-12-31
Other Creditors
Current
2,056 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
18,806 GBP2023-12-31
Creditors
Current
38,245 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
121,405 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.0012022-10-25 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
86,819 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.0012022-10-25 ~ 2023-12-31
  • CREDO THERAPIES LTD
    Info
    Registered number 14441022
    8 King Edward Street, Oxford OX1 4HL
    Private Limited Company incorporated on 2022-10-25 (2 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.